Eur Rev Med Pharmacol Sci 2020; 24 (13): 7202-7202
DOI: 10.26355/eurrev_202007_21852

MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway

J.-H. Fu, S. Yang, C.-J. Nan, C.-C. Zhou, D.-Q. Lu, S. Li, H.-Q. Mu

Department of Urology, Dongyang People’s Hospital, Dongyang, Zhejiang, China.


Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, “MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway, by J.-H. Fu, S. Yang, C.-J. Nan, C.-C. Zhou, D.-Q. Lu, S. Li, H.-Q. Mu, published in Eur Rev Med Pharmacol Sci 2018; 22 (2): 351-357–DOI: 10.26355/eurrev_201801_14179–PMID: 29424922” has been withdrawn.

The Publisher apologizes for any inconvenience this may cause.

MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway

Free PDF Download

To cite this article

J.-H. Fu, S. Yang, C.-J. Nan, C.-C. Zhou, D.-Q. Lu, S. Li, H.-Q. Mu
MiR-182 affects renal cancer cell proliferation, apoptosis, and invasion by regulating PI3K/AKT/mTOR signaling pathway

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 13
Pages: 7202-7202
DOI: 10.26355/eurrev_202007_21852